A. Purpose and applicability B. Legal principles and formal aspects of the reports... 2

Size: px
Start display at page:

Download "A. Purpose and applicability B. Legal principles and formal aspects of the reports... 2"

Transcription

1 Bundesamt für Veterinärwesen Office vétérinaire fédéral Ufficio federale di veterinario Uffizi federal veterinar Information Animal protection 1.03 Reports on animal experiments: Explanatory notes for Form C Contents Page A. Purpose and applicability... 2 B. Legal principles and formal aspects of the reports... 2 C Explanations of the individual sections... 3 Heading: Number of the licence... 3 Heading: Final report/interim report... 3 Heading: Year of the report... 3 Heading: Intercantonal experiment... 3 Heading: Short title of the project... 3 Section 1: Address of resource manager... 4 Section 2: Address of cantonal authority... 4 Section 3: Completion of the experiment / continuation in the following year... 4 Section 4: Number of animals used in the calendar year... 4 Section 5: Origin of the animals used... 6 Section 6: Retrospective degree of severity... 7 Section 7: Elimination or further use of the animals... 9 Section 8: Assessment of the experiment Section 9: The undersigned resource manager Final section: Confirmation by the cantonal authority V1.3 august 2011

2 - 2 - A. Purpose and applicability The legislator wishes to establish clarity in respect of animal experimentation and, by doing so, to promote an objective discussion of this controversial topic. The Swiss Federal Veterinary Office publishes annual statistics covering all experiments on animals. These contain the information needed to assess the application of the legislation on the animal welfare (art. 36, Animal Welfare Act, TSchG; RS 455). In the compilation and publication of statistics, compliance with international rules and recommendations is required (see art. 147, para. 2, Animal Welfare Ordinance, TSchV; RS 455.1). For this the collection of complete and reliable data on the number of animals used in the experiments, their origin and the purpose of their use, the adverse effects of the experiment is needed etc. For this purpose, all persons who conduct animal experiments must present an annual report (Form C; cf. art. 145, paras 2 and 4 TSchV). The information contained in Form C is also consulted during the verification of animal experiments already conducted. The purpose of these explanatory notes for Form C is to facilitate the drafting of reports and so to reduce the number of subsequent enquiries made by the authorities. They are to be regarded as a work of reference for consultation if any doubts arise over the completion of individual sections of Form C. The explanatory notes for Form C are intended for all holders of a cantonal permit to conduct animal experiments and for the authorizing authorities. These explanations only relate to Form C. Separate explanations apply to Form A (Applications; FVO no (e)). B. Legal principles and formal aspects of the reports The responsible resource manager shall report completion of experiments within two months of their completion to the cantonal authority by means of Form C. Where experiments continue over a number of years, the notification must be given with the requisite information for the past calendar year by the end of February at the latest (see art. 145, para. 1, TSchV ). The reports are to be submitted according to the form template of the Federal Veterinary Office (Form C), cf. art. 31, para. 1 Animal Experiment Ordinance, TVV). The form are available for download here: The original and one copy of the report are to be submitted to the cantonal authority, which may require further copies from the licence holder. Further instructions given by the cantonal authorities, e.g. as to whether copies of cited literature are to be attached, must be respected. Note: Once the information system e-tierversuche is operational, reports are to be completed online (art. 145 para 2 TSchV). If no animal experiments are carried out within the context of an existing licence during the reporting year,

3 - 3 - it is sufficient to send the cantonal authorities a brief notification ( , letter) to this effect instead of the completed form. C Explanations of the individual sections The explanations of the individual sections show the purpose for which a particular item of information is required, the content that is expected and particular details to be noted. The explanatory examples given for some sections clarify the required content. Heading: Number of the licence PURPOSE OF ENTRY: Clear identification of the report and association with the corresponding licence. Enter the official licence number (see Form B or possibly pre-numbered by the cantonal authority). EXAMPLES: 2361 BE118/09 ZG21 Heading: Final report/interim report PURPOSE OF ENTRY: Fast and unambiguous identification of completed research projects (final report: close file). For research projects which are to be continued under the same licence number in the following year, the reports are regarded as interim reports. Mark a cross in the appropriate box. Heading: Year of the report PURPOSE OF ENTRY: Clear identification of the reporting year. Enter the year. Heading: Intercantonal experiment PURPOSE OF ENTRY: Rapid identification of cross-cantonal animal experiments. Tick where applicable Heading: Short title of the project PURPOSE OF ENTRY: To facilitate identification of the report by the authorities and cantonal committees. This information is used for verification purposes if the licence number does not coincide.

4 - 4 - Use the same wording as on the licence (Form B). The short title should indicate the purpose of the experiment and give references to the animal model or method used. EXAMPLES: Experimental meningitis in mice. Polyclonal antibodies of chickens against enzymes which influence DNA replication. Section 1: Address of resource manager PURPOSE OF ENTRY: Used for correspondence with the authorities. Postal address of the institute, laboratory or company, together with name, telephone number and of the resource manager. Section 2: Address of cantonal authority PURPOSE OF ENTRY: Used for correspondence with the authorities. Postal address of the responsible cantonal authority (generally pre-printed, e.g. Kantonales Veterinäramt Zürich, Domaine de l'expérimentation animale, Direction générale de la santé, Genève) Section 3: Completion of the experiment / continuation in the following year PURPOSE OF ENTRY: To inform the authorities whether the animal experiment has already been completed at the time of reporting or is to be continued (subject to the validity of the licence). Mark a cross in the appropriate box. Where necessary indicate the month and year of completion of the experiment. Section 4: Number of animals used in the calendar year PURPOSE OF ENTRY: Used to compile data for annual statistics pursuant to Art. 36, para. 3 TSchG and 147 TSchV. Complete one column for each species of animal. Enter the name of the animal species at the top. Genetically modified lines: One column each is to be used for the wild type and one for the summary of genetically modified lines. Cross-cantonal experiments (art. 27 TVV): in experiments that concern several cantons, one column is to be completed for each animal species for each canton. If the same animals were used in several cantons, this must be explicitly mentioned in Section 44. However, each individual should be counted but once. Larvae and embryos (art. 112 c and d TSchV): embryos in the last trimester of the development period before birth or hatching and larva stages that are already ingesting food freely are likewise counted. If they have not yet reached birth or completed the

5 - 5 - metamorphosis at the end of the experiment, they are to be defined as embryos or larvae and reported in a separate column. Every animal that was used in an animal experiment at any time in the reporting year (1 January to 31 December) should be counted once, regardless of whether the animal belongs to the experimental group or is an untreated control animal, eliminated during the experiment etc. If an animal was already used in the same experiment in the previous year (same licence number), it is shown under Section 41, otherwise under Section 42. If animals were used several times for the same or different experiments in the reporting year (different licence numbers), this must also be in Section 44. Otherwise they will be counted as normal species. If more than three columns are needed, complete a further Form C. Section 41: Number of animals taken over from the previous year under this licence number Indicate the number of animals which were used under the same licence number in the previous year and are still in use in the reporting year, i.e. animals which remain in the experiment after the year-change to the reporting year. Examples include chronic toxicity studies or repeated use of rabbits in pyrogen tests (this number corresponds to the number of animals reported in Section 72 in the previous year). Section 42: Number of animals newly used under this licence number in the reporting year State the number of animals newly used in the reporting year. Count animals which were used for the first time for experimental purposes and those which were used in the previous year for a different experiment that has been concluded in the meantime. Section 43: Total number of animals used in the reporting year under this licence number State the total number of animals used in this experiment in the reporting year (total of sections 41 and 42). Section 44: Number of animals used repeatedly in the reporting year under this or another licence number PURPOSE OF ENTRY: Determination of re-use and repeated use as defined in the European Convention on the Protection of Vertebrates used for animal experiments and other scientific purposes (Convention of the Council of Europe 123), resolution of the ad hoc Committee of Experts on the Convention of 27 November 1992: Animals that are used twice or more times during the reporting year in the same experiment or in different experiments although for scientific reasons, different individuals could equally have been used. Examples include the repeated use of primates from the same colony for different pharmacological tests and the testing of different substances for their cardiovascular effect on chronically instrumented dogs. Indicate the number of animals which were used twice or more in the reporting year under this licence or additionally under a different licence.

6 - 6 - Ad Section 44: In the case of re-use or repeated use of animals, indicate, where appropriate, the licence number under which the animals were additionally used PURPOSE OF ENTRY: To verify Article 135, para. 8 TSchV, according to which animals must not be used repeatedly in experiments involving high a level of stress (SG3). In the case of re-use or repeated use of animals, the experiments in which the animals were used must be known. This information is also necessary to ensure that animals used repeatedly in the same reporting year are only counted once. Complete only if multiple use of the animals has been made. State the licence number. Section 5: Origin of the animals used PURPOSE OF ENTRY: Compilation of annual statistics on the origin of the animals pursuant to the European Convention on the Protection of Vertebrates used for experiments and other scientific purposes (Convention of the Council of Europe); Resolution of the ad-hoc Committee of Experts on the Convention of 27 November 1992 (see Art. 64b, APL). The indications of origin concern all the individuals used in the reporting year. The total number of animals in the relevant columns of Sections 51 to 54 must correspond to the number of animals stated in Section 43. The animals listed in Section 41 must be counted in Section 51. Section 51: Number of animals originating from the current experiment (as stated in Section 41) or from an earlier animal experiment that has been completed State the number of animals which were involved in an ongoing experiment at the start of the reporting year (Section 41) or which originate from a previous completed animal experiment. For example, primates from permanent colonies or cattle in the stables of research establishments which were used twice or more often in an experiment must be counted under this section. Section 52: Number of animals originating from a licensed laboratory animal husbandry in Switzerland State the number of animals obtained from a licensed animal unit in Switzerland (art. 122 TSchV) and used for the first time in an experiment. Section 52 applies for lab animals according to the European Convention (RS 0.457, art.21): Mice, rats, hamster, guinea-pigs, rabbits, dogs, cats, primates, quails, including genetically modified lines of these species. Animals originating from Switzerland, but not from a licensed animal unit (working animals, pets or wild animals as defined in art. 122, para. 8, TSchV) are to be counted under Section 54. Section 53: Number of animals obtained from an animal breeding station or dealer abroad State the number of animals which were procured from a foreign breeding station or

7 - 7 - supplier for experimental animals - regardless of whether the station is recognized by the national authorities concerned - and used for the first time in an experiment. Section 53 applies for lab animals according to the European Convention (RS 0.457, art.21): Mice, rats, hamster, guinea-pigs, rabbits, dogs, cats, primates, quails, including genetically modified lines of these species. Ad Section 53: When animals are procured abroad, state the country of origin Complete only if an entry was made under Section 53: State the country of origin. Section 54: Number of animals of other origin respectively: other animal species from those in 52 and 53 Indicate the number of animals which - do not originate from an incomplete or previous animal experiment (cf. Section 51) - or from a licensed animal unit in Switzerland (cf. Section 52) - or from a breeding station or dealer in experimental animals abroad (cf. Section 53). For example, zoo animals and households pets used in clinical studies or studies in working animals or wild animals are to be counted here. Ad Section 54: Describe other origin and state number of animals concerned EXAMPLES: Only complete if an indication has been given in Section 54. The origin must be described for the different species. If the animals originate from different sources, the numbers concerned must be stated separately. Patient animals in field studies. Working animals Wild animals. Section 6: Retrospective degree of severity PURPOSE: Compilation of the annual statistics pursuant to art. 36, TSchG containing the information needed to permit an assessment of compliance with animal welfare legislation. One of the main purposes of the law in relation to animal experiments is to limit the stress on individual animals. The publication of statistical data regarding the stress on the animals will contribute to this purpose and ensure transparent information on animal experiments. After the end of the experiment, the degree of severity will be determined according to the actual (estimated) adverse effects on the individual animals or groups of animals, having regard to any failure of the experiment to run according to plan, i.e. under circumstances which diverge from those stated in the application for the licence. In particular, the retrospective degrees of severity must be stated separately for animals and groups of animals within the experiment (cf. art. 24 TVV). Criteria and notes for the correct classification of animals are set out in two information leaflets of the Federal Veterinary Office ( Einteilung von Tierversuchen nach Schweregraden FVO nos and ).

8 - 8 - Note: The severity grades are entered unchanged as stipulated in the abovementioned FVO information leaflets. Possible adaptations with regard to the dignity (article 3 TSchG) and genetically related stresses (articles 25 and 26 TVV) are currently under discussion, but will not enter into force until the publication of a new set of guidelines on severity grades at the earliest. For animals which are still to be used after the end of the year in the experiment which continues in the following year, the degree of severity of the adverse effects up to that time must be stated. In long-term studies (e.g. lifetime toxicity study), spontaneously deceased animals must be allocated to severity degree 3 (Section 64). If an autopsy shows clearly that death was immediate, causing no heavy constraints, a lower degree will be allocated. If such animals were eliminated by euthanasia in an earlier stage of clinical symptoms, a correspondingly lower degree of severity will be allocated (Section 62 or 63). The sum of the Sections 61 to 64 must correspond to the indication given in Section 43. EXAMPLE: Determination of the oral subchronic toxicity of an agricultural chemical on a dog pursuant to guideline No. 409 of the OECD for the testing of chemicals. Sixteen animals are used in three dose groups and one control group. The animals undergo clinical examination once or twice each day; at intervals of five weeks on two occasions, a blood sample is taken and a catheter inserted into the bladder. The animals in the highest and medium dose group showed medium to medium-severe clinical symptoms, while those in the lower dose group only showed brief symptoms on one occasion and those in the control group no clinical symptoms whatever. This gives the following distribution: No adverse effect --> Sec. 61: 0 animals Degree of severity 1 --> Sec. 62: 8 animals Degree of severity 2 --> Sec. 63: 8 animals Degree of severity 3 --> Sec. 64: 0 animals Section 61: Number of animals without adverse effects (degree of severity 0) Indicate the number of animals for which the interventions and measures that were carried out for experimental purposes did not inflict any pain, suffering or damage, instil fear or impair their general wellbeing. As a general rule, animals used for non-stressful experiments or control animals in which no stressful procedures were carried out are to be counted under this heading. Section 62: Number of animals with degree of severity 1 Indicate the number of animals for which the interventions and measures that were carried out for experimental purposes caused slight, short-term pain or damage or impaired slightly their general wellbeing. For example, temporarily anaesthetized animals for MRI measurements or rabbits immunized without the use of Freund s adjuvant are to be counted under this heading. Section 63: Number of animals with degree of severity 2

9 - 9 - Indicate the number of animals for which the interventions and measures that were carried out for experimental purposes caused moderate, short-term or slight, medium to long-term pain, suffering or damage, instilled short-term moderate fear or a substantial, short to medium-term impairment of general wellbeing. For example animals that had electrodes implanted in the brain or that underwent adrenalectomy are to be counted here. Section 64: Number of animals with degree of severity 3 Indicate the number of animals for which the interventions and measures that were carried out for experimental purposes caused medium to long-term moderate or severe pain, lasting moderate to severe suffering, medium to long-term moderate or severe damage, substantial and lasting fear or substantial and lasting impairment of general wellbeing. For example animals which underwent thoracotomy or ischemia of the brain with subsequent substantial functional disorders and animals which died in severe pain that had not been anticipated are to be counted here. Section 7: Elimination or further use of the animals PURPOSE OF ENTRY: State the number of animals which were still being used in the experiment at the end of the year or which had not been eliminated by euthanasia at the end of the experiment and provide information on the planned further use of these animals. The sum of Sections 71 to 73 must correspond to the figure stated in Section 43, i.e. all the animals used in the reporting year must be listed. Section 71: Animals euthanized or perished during or at the end of the experiment State the number of animals which were no longer alive at the end of the experiment or at the end of the year. Count all animals which were killed at the end of the experiment or eliminated by premature euthanasia because of illness or for other reasons and animals used in experiments with lethal consequences. Section 72: Surviving animals to be used for continuation of the experiment in the next year State the number of live animals which were still being used at the end of the reporting year in the experiment which is scheduled to continue in the next year (under the same licence number). For example, count animals which are used in chronic toxicity studies lasting beyond the beginning of the following year (this number will correspond to the number of animals stated in Section 41 in the next reporting year). Section 73: Surviving animals at the end of the experiment State the number of animals which were alive, were not killed and are no longer to be used under this licence number at the end of the experiment (use in later experiments, released as experimental animals).

10 Ad Section 73: Describe use of surviving animals after completion of the experiment and state the number of animals concerned Complete only if an entry has been made in Section 73. The purpose of use must be described for the different animal species. If the animals were intended for different purposes, state the relevant numbers separately. EXAMPLES: Dogs from a clinical study remain with the animal keepers Zoo animals remain in the zoo Wild animals remain in the wild Cattle or primates from permanent stocks for later use in other animal experiments Working animals that are passed on for regular slaughter after the experiment. Section 8: Assessment of the experiment PURPOSE OF ENTRY: To provide information for the cantonal authorities and the cantonal experimentation committees on the success or failure of the experiments and on their continuation. Section 81: Results achieved with regard to the purpose of the experiment and the gain in knowledge Concise description of the results obtained in the reporting year, with special reference to the purpose of the experiment and the gain in knowledge (interpretation of the results). The further objective must be stated in interim reports (i.e. for projects which are to be continued). Section 82: For toxicological studies: state the number of substances tested, number of animals per substance Complete only if standard tests are conducted as part of the verification of the impact and non-toxicity of pharmaceutical preparations and toxicity tests of other substances and products. State the number of tested substances and number of animals per substance, summarized by substance for which the same number of animals were used in each case. In the event of deviations from the standard values, also state the number of doses and the number of animals in each group. Give reasons for deviations. In the case of licences that comprise more than one standard protocol: additional breakdown of figures by the different standard protocols (see also Toxicity Directive FVO No ). Section 83: Suitability of the method, animal species and number of animals. Any changes in method as agreed on with cantonal authority. Potential in respect of 3R Describe the method used, the species and number of animals (group size) in respect of their suitability for the achievement of the aim of the experiment. State any methodological difficulties and changes in method, including any agreements with the cantonal authorities. Give reasons for changes and explain expectations

11 placed in the changed method. State the development of new methods. Estimate refinement and potential for 3R. Section 84: Special events State any unforeseen events which had an impact on the conduct of the experiment. Examples include illnesses, accidents, technical breakdowns, personnel problems. Indicate any delayed start of the experiment or abandon of the experiment. Section 85: Planned reports and publications State reports and/or publications which have already appeared and are planned. State the authors, title, journal/place of publication and source. Enclose a copy for the authority, where appropriate. Section 9: The undersigned resource manager PURPOSE: The undersigned resource manager (Section 38 of the application) is the responsible holder of the licence. He/she bears responsibility for reporting the animals used in the previous year by the stipulated date (Form C) and confirms by his or her signature that the experiment was conducted by the study director in compliance with Section 39 of the application and that the information is complete and correct. Place and date, name and signature. Final section: Confirmation by the cantonal authority PURPOSE: Confirmation by the cantonal authority that the completeness of the indications given in the report was checked and that the contents appear plausible. Place and date, name and signature. Note: Find the European Convention on the Protection of Vertebrates used for Experiments and other Scientific Purposes and the Resolution of the Ad Hoc Committee of Experts to the Convention of the 27 th November 1992 can be found at

Licence application to perform animal experiments: Explanatory notes to form A

Licence application to perform animal experiments: Explanatory notes to form A Bundesamt für Veterinärwesen Office vétérinaire fédéral Ufficio federale di veterinario Uffizi federal veterinar Information Animal welfare 1.02 Licence application to perform animal experiments: Explanatory

More information

Explanatory notes on the annual report on laboratory animal facility (Form CH)

Explanatory notes on the annual report on laboratory animal facility (Form CH) Federal Department of Home Affairs FDHA Federal Food Safety and Veterinary Office FSVO Animal Welfare Information on animal experimentation Explanatory notes on the annual report on laboratory animal facility

More information

Licence application and notification of animal experiments: explanatory notes for Form A. A Purpose and applicability 2

Licence application and notification of animal experiments: explanatory notes for Form A. A Purpose and applicability 2 Bundesamt für Veterinärwesen Office vétérinaire fédéral Ufficio federale di veterinario Uffizi federal veterinar Information Animal protection 1.02 Licence application and notification of animal experiments:

More information

CCAC Animal Data Report

CCAC Animal Data Report 2016 CCAC Animal Data Report Canadian Council on Animal Care Conseil canadien de protection des animaux ACKNOWLEDGMENTS The Canadian Council on Animal Care (CCAC) extends our sincere thanks to all those

More information

Annual statistical report for animals used in Ireland under scientific animal protection legislation

Annual statistical report for animals used in Ireland under scientific animal protection legislation Annual statistical report for animals used in Ireland under scientific animal protection legislation - 2017 15 NOV 2018 Table of Contents 1 INTRODUCTION... 3 2 SUMMARY... 5 3 RESULTS... 6 3.1 Species and

More information

Annual statistical report for animals used in Ireland under scientific animal protection legislation

Annual statistical report for animals used in Ireland under scientific animal protection legislation Annual statistical report for animals used in Ireland under scientific animal protection legislation - 2016 09 OCT 2017 Table of Contents 1 INTRODUCTION... 3 2 SUMMARY... 5 3 RESULTS... 6 3.1 Species and

More information

INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC) PACIFIC LUTHERAN UNIVERSITY TACOMA, WA PHONE: (253) FAX: (253)

INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC) PACIFIC LUTHERAN UNIVERSITY TACOMA, WA PHONE: (253) FAX: (253) INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC) PACIFIC LUTHERAN UNIVERSITY TACOMA, WA 98447-0001 PHONE: (253)535-7126 FAX: (253) 535-8760 PROTOCOL FOR ANIMAL CARE AND USE IACUC Approval Form (Created

More information

Vertebrate Animal Use Protocol for Research or Testing

Vertebrate Animal Use Protocol for Research or Testing AUP #: ORC USE ONLY Vertebrate Animal Use Protocol for Research or Testing Date Received: Instructions and Researcher Certifications (Failure to follow may result in a delay in processing) Complete this

More information

REQUEST FORM FOR RESEARCH PROTOCOL APPROVAL. For IACUC Use Only: Major Survival Surgery Pain Category E studies Hazardous Agents

REQUEST FORM FOR RESEARCH PROTOCOL APPROVAL. For IACUC Use Only: Major Survival Surgery Pain Category E studies Hazardous Agents 1 AMERICAN UNIVERSITY OF BEIRUT INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE REQUEST FORM FOR RESEARCH PROTOCOL APPROVAL For IACUC Use Only: Proposal : Date of Approval: The PI plans to perform / to use:

More information

Page 1 Executive Summary 2 2 Introduction

Page 1 Executive Summary 2 2 Introduction ANIMALS (SCIENTIFIC PROCEDURES) ACT 1986 USE, CONTINUED USE AND RE USE OF ANIMALS Contents: Page 1 Executive Summary 2 2 Introduction 3 Definition of Terms: 3.1 use 3 3.2 Continued use 3.3 Re use 4 Authorisation

More information

ANIMAL ETHICS APPLICATION GUIDANCE FOR FASTER ANIMAL ETHICS APPROVAL

ANIMAL ETHICS APPLICATION GUIDANCE FOR FASTER ANIMAL ETHICS APPROVAL ANIMAL ETHICS ANIMAL ETHICS APPLICATION GUIDANCE FOR FASTER ANIMAL ETHICS APPROVAL This Animal Ethics Application Guidance document should be used as a companion document whilst completing an Animal Ethics

More information

1. STUDY TEAM - ANIMAL CARE COMMITTEE

1. STUDY TEAM - ANIMAL CARE COMMITTEE Note: This printout is a summary of the data contained in the online application. Please refer to the application itself ("View Application") for full details. Sections where the application contains information

More information

GUIDELINES FOR COMPLETING THE ANIMAL ETHICS APPLICATION FOR RESEARCH AND TEACHING

GUIDELINES FOR COMPLETING THE ANIMAL ETHICS APPLICATION FOR RESEARCH AND TEACHING ANIMAL ETHICS COMMITTEE GUIDELINES FOR COMPLETING THE ANIMAL ETHICS APPLICATION FOR RESEARCH AND TEACHING GENERAL INFORMATION Research on animals is subject to both federal and state legislation, and the

More information

Swiss Federal Banking Commission Circular: Audit of Banks and Securities Firms. 29 June 2005 (Latest amendment: 24 November 2005)

Swiss Federal Banking Commission Circular: Audit of Banks and Securities Firms. 29 June 2005 (Latest amendment: 24 November 2005) SFBC Circular 05/1 Audit Page 1 Swiss Federal Banking Commission Circular: Audit of Banks and Securities Firms (Audit) 29 June 2005 (Latest amendment: 24 November 2005) Contents I. Introduction A. Scope

More information

ANIMAL ETHICS APPLICATIONS

ANIMAL ETHICS APPLICATIONS TOP TIPS FOR SUCCESS IN ANIMAL ETHICS APPLICATIONS UQ RESEARCH AND INNOVATION UQ RESEARCH AND INNOVATION UQ s innovations have, and continue to make, life-changing advances. The University is committed

More information

LESSON 5.3 WORKBOOK. Should animals be used in scientific research?

LESSON 5.3 WORKBOOK. Should animals be used in scientific research? LESSON 5.3 WORKBOOK Should animals be used in scientific research? In the last couple of lessons we have referred to experiments in which laboratory animals have been used to test the adverse effects of

More information

The clock is ticking...

The clock is ticking... w w w. a - t u n e. c o m Directive 2010/63/EU adopted The clock is ticking... The clock is ticking... - P a g e 2 - After more than 10 years of discussion, the European Parliament gave a first reading

More information

APPLICATION FOR APPROVAL TO USE ANIMALS IN A RESEARCH OR TEACHING PROJECT

APPLICATION FOR APPROVAL TO USE ANIMALS IN A RESEARCH OR TEACHING PROJECT APPLICATION FOR APPROVAL TO USE ANIMALS IN A RESEARCH OR TEACHING PROJECT te: Please do not copy and submit this page with your application. Background All scientific procedures using animals must be carried

More information

Guideline on Good Pharmacovigilance Practices Module V- Pharmacovigilance System Master File

Guideline on Good Pharmacovigilance Practices Module V- Pharmacovigilance System Master File Guideline on Good Pharmacovigilance Practices Module V- Pharmacovigilance System Master File Turkish Medicines and Medical Devices Agency 16.02.2015 CHAPTER I... 2 1.1. Introduction... 2 CHAPTER II...

More information

THE UNIVERSITY OF HOUSTON IACUC POLICY

THE UNIVERSITY OF HOUSTON IACUC POLICY THE UNIVERSITY OF HOUSTON IACUC POLICY Title: IACUC Protocol Review Background: The Animal Welfare Act and Animal Welfare Regulations (AWAR); Guide for the Care and Use of Laboratory Animals ( the Guide

More information

An Overview of Laboratory Animal Transportation

An Overview of Laboratory Animal Transportation An Overview of Laboratory Animal Transportation William J. White, V.M.D., M.S., DACLAM, DECLAM Corporate Vice President, Veterinary and Prof. Services Charles River Laboratories What are laboratory animals?

More information

The Organisation of Nuclear Installations ENSI-G07. Guideline for Swiss Nuclear Installations. July 2013 Edition

The Organisation of Nuclear Installations ENSI-G07. Guideline for Swiss Nuclear Installations. July 2013 Edition Guideline for Swiss Nuclear Installations ENSI-G07 July 2013 Edition July 2013 Edition Guideline for Swiss Nuclear Installations ENSI-G07/e Contents Guideline for Swiss Nuclear Installations ENSI-G07/e

More information

Support of refinement by the NC3Rs: Experiences and recommendations. Mark Prescott, PhD BfR-Forum, 13 December 2011

Support of refinement by the NC3Rs: Experiences and recommendations. Mark Prescott, PhD BfR-Forum, 13 December 2011 Support of refinement by the NC3Rs: Experiences and recommendations Mark Prescott, PhD BfR-Forum, 13 December 2011 The NC3Rs Independent, scientific organisation Established by UK Government in 2004 Use

More information

Discussion paper for the stakeholder meeting of 9 December 2014

Discussion paper for the stakeholder meeting of 9 December 2014 Discussion paper for the stakeholder meeting of December Background 1 1 1 0 1 Regulation (EU) No / (hereafter: the basic Regulation) establishes rules governing compliance with access and benefit-sharing

More information

Initial Reporting of Animal Welfare Concern to the Institution

Initial Reporting of Animal Welfare Concern to the Institution IACUC POLICY INVESTIGATING ANIMAL WELFARE CONCERNS & NONCOMPLIANT ACTIVITIES To ensure the humane care and treatment of animals used in research, teaching, and testing, the Drexel University Institutional

More information

INSTRUCTIONS FOR COMPLETION OF THE CCAC ANIMAL USE DATA FORM

INSTRUCTIONS FOR COMPLETION OF THE CCAC ANIMAL USE DATA FORM INSTRUCTIONS FOR COMPLETION THE CCAC ANIMAL USE DATA FORM TABLE CONTENTS 1. PREAMBLE... 1 2. INTRODUCTION... 1 3. TO BE INCLUDED ON THE AUDF... 2 4. REQUIRED ELEMENTS... 2 1. Unique Protocol Number...

More information

University Council on Animal Care

University Council on Animal Care Policy: Animal Use Protocols Category: Administration Subject: The generation, review and approval of Animal Use Protocols Approving Authority: University Council on Animal Care Responsible Office: Animal

More information

The revised European Directive 2010/63/EU: a guide for UK institutions

The revised European Directive 2010/63/EU: a guide for UK institutions The revised European Directive 2010/63/EU: November 2010 Process of revision The new European Directive 2010/63/EU (to replace EU 86/609) was finalised and came into force across the EU in November 2010.

More information

H5NG 04 (SCDHSC0027) Support Individuals in Their Daily Living

H5NG 04 (SCDHSC0027) Support Individuals in Their Daily Living H5NG 04 (SCDHSC0027) Support Individuals in Their Daily Living Overview This standard identifies the requirements when supporting individuals in their daily living. This includes working with individuals

More information

Regulation on Animal Experimentation

Regulation on Animal Experimentation Please note: This is NOT an authorised translation of the Norwegian Regulation on Animal Experimentation (Forskrift om forsøk med dyr). The text of this Regulation may well undergo changes in the future.

More information

List the names of all students authorized to conduct procedures involving animals under this proposal

List the names of all students authorized to conduct procedures involving animals under this proposal July 2013 COLORADO COMMUNITY COLLEGE SYSTEM ANIMAL STUDY PROPOSAL PLEASE TYPE A. ADMINISTRATIVE DATA Leave Blank Proposal #: Approval Date: Expiration Date: College Department: Principal Student Investigator:

More information

Institutional Animal Care & Use Program - UTEP Title: Adjuvant Use in Laboratory Animals Policy#: 007 Date in Effect: 11 December 2014

Institutional Animal Care & Use Program - UTEP Title: Adjuvant Use in Laboratory Animals Policy#: 007 Date in Effect: 11 December 2014 IACUC Policy #007, Page 1 of 5 Institutional Animal Care & Use Program - UTEP Title: Adjuvant Use in Laboratory Animals Policy#: 007 Date in Effect: 11 December 2014 Version #: A Rev Date: In Effect Rescinded

More information

ACVM - REGISTRATION STANDARD FOR TOXICOLOGY AND ENVIRONMENTAL TOXICOLOGY

ACVM - REGISTRATION STANDARD FOR TOXICOLOGY AND ENVIRONMENTAL TOXICOLOGY ACVMS 9.1 Ministry of Agriculture and Forestry Post Office Box 2526 WELLINGTON, NEW ZEALAND ACVM - REGISTRATION STANDARD FOR TOXICOLOGY AND ENVIRONMENTAL TOXICOLOGY This document may be altered at any

More information

Type: Embedded within the selected substance, indicated when creating the substance.

Type: Embedded within the selected substance, indicated when creating the substance. Overview: Substance Table: Each procedure will include a substance table, either on the main page of the procedure (immediately after selecting the procedure type), embedded elsewhere within a procedure,

More information

Animal Experimentation

Animal Experimentation Animal Experimentation An HRC Research Primer Report in Brief This primer summarizes the available quantitative research relating to animal experimentation, including the number of animals used for experiments

More information

Guidance for Industry Compounding Animal Drugs from Bulk Drug Substances

Guidance for Industry Compounding Animal Drugs from Bulk Drug Substances #230 Guidance for Industry Compounding Animal Drugs from Bulk Drug Substances DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this

More information

Perspectives on the Ethical Evaluation in the revised Directive 86/609/EEC

Perspectives on the Ethical Evaluation in the revised Directive 86/609/EEC Perspectives on the Ethical Evaluation in the revised Directive 86/609/EEC Rome, 4.5.2009 Marcelle Holloway Revision of Directive 86/609/EEC Part I Why the revision? Starting point and the process Key

More information

GUIDELINE REGARDING COLLECTION, VERIFICATION, AND SUBMISSION OF THE REPORTS OF ADVERSE EVENTS / REACTIONS OCCURRING IN CLINICAL DRUG TRIALS

GUIDELINE REGARDING COLLECTION, VERIFICATION, AND SUBMISSION OF THE REPORTS OF ADVERSE EVENTS / REACTIONS OCCURRING IN CLINICAL DRUG TRIALS 1. PURPOSE This guideline is about the collection, verification, and submission of the reports of adverse events / reactions occurring in clinical drug trials, and code breaking methods. 2. DEFINITIONS

More information

Standard Operating Procedures Guidelines for Good Clinical Practice

Standard Operating Procedures Guidelines for Good Clinical Practice SOP # CRSC-105 Effective Date 10-22-2013 Version # 1 Version Date 7-30-2013 Standard Operating Procedures Guidelines for Good Clinical Practice Purpose: This SOP outlines the steps required to follow FDA

More information

Texas A&M University-Commerce Institutional Animal Care and Use Committee Animal Care and Use Application Teaching

Texas A&M University-Commerce Institutional Animal Care and Use Committee Animal Care and Use Application Teaching Texas A&M University-Commerce Institutional Animal Care and Use Committee Animal Care and Use Application Teaching Principal Investigator Name: Department: Campus Address: Campus Phone Number: Email Rank:

More information

Farm registration and movement of farm livestock

Farm registration and movement of farm livestock Farm registration and movement of farm livestock Registering your land as an agricultural holding Before moving livestock to your school land (holding) you need a County Parish Holding (CPH) number for

More information

Detection of toxicity to reproduction for human pharmaceuticals. Explanatory slides agreed by EWG members

Detection of toxicity to reproduction for human pharmaceuticals. Explanatory slides agreed by EWG members Detection of toxicity to reproduction for human pharmaceuticals Explanatory slides agreed by EWG members 2 October 2017 International Council for Harmonisation of Technical Requirements for Pharmaceuticals

More information

Animal Experiment Statistics

Animal Experiment Statistics BRIEFING PAPER Number 02720, 12 April 2018 Animal Experiment Statistics By Georgina Sturge Inside: 1. Background 2. Overall trends in procedures 3. Types of procedure 4. Species and origin 5. Severity

More information

The development of a national guideline to promote the wellbeing of animals used for scientific purposes

The development of a national guideline to promote the wellbeing of animals used for scientific purposes AATEX 14, Special Issue, 85-89 Proc. 6th World Congress on Alternatives & Animal Use in the Life Sciences August 21-25, 2007, Tokyo, Japan The development of a national guideline to promote the wellbeing

More information

Public Interest Incorporated Foundation BioSafety Research Center

Public Interest Incorporated Foundation BioSafety Research Center Public Interest Incorporated Foundation BioSafety Research Center http://www.anpyo.or.jp Ver. 201801 Building #1(Test and research annex) Building #2 (Administrat ion office) Building #3 (Toxicity test

More information

CORPORATE MANUAL OF INTEGRATED MANAGEMENT SYSTEM

CORPORATE MANUAL OF INTEGRATED MANAGEMENT SYSTEM CORPORATE MANUAL OF INTEGRATED MANAGEMENT SYSTEM SIAD Macchine Impianti, the Company leader of SIAD Group's Engineering Pag. 1 di 20 Contents INTRODUCTION... 4 FOREWORD... 4 1. SCOPE... 5 2. REFERENCES...

More information

NIH Adopts 8 th Edition of the Guide: A Discussion

NIH Adopts 8 th Edition of the Guide: A Discussion 1 NIH Adopts 8 th Edition of the Guide: A Discussion Patricia Brown, VMD, MS, DACLAM Director, OLAW, NIH OLAW Online Webinar December 8, 2011 Oversees the welfare of research animal subjects in PHS-funded

More information

Animal Use Protocol. Name: Signature: Date:

Animal Use Protocol. Name: Signature: Date: Animal Use Protocol Protocol Title: Please Leave Blank Proposal #: Approval Date: Expiration Date: PRINCIPAL INVESTIGATOR CERTIFICATION A. I certify that I have attended the institutionally required investigator

More information

FDA approval of emergency expanded access use may be requested by telephone, facsimile, or other means of electronic communications.

FDA approval of emergency expanded access use may be requested by telephone, facsimile, or other means of electronic communications. Guidelines for the Submission of an Expanded Access IND to Permit Diagnosis, Monitoring or Treatment of an Individual Patient with an Investigational Drug or a REMS-restricted, Approved Drug Guidelines:

More information

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL STUDY PROTOCOL CHAPTER 14 REVISED: OCTOBER 2015

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL STUDY PROTOCOL CHAPTER 14 REVISED: OCTOBER 2015 THE STUDY PROTOCOL The study protocol is a written document detailing how a clinical trial is conducted. The elements of a protocol include: 1. Trial design and organization; 2. Study objectives; 3. Background

More information

Clinical trial information leaflet and consent

Clinical trial information leaflet and consent Informed consent 1(7) Clinical trial information leaflet and consent General You must provide sufficient information on the rights of clinical trial subjects, the purpose and nature of the trial, the methodologies

More information

H5PW 04 (SCDHSC0419) Provide Advice and Information to Those Who Enquire About Health and Social Care Services

H5PW 04 (SCDHSC0419) Provide Advice and Information to Those Who Enquire About Health and Social Care Services H5PW 04 (SCDHSC0419) Provide Advice and Information to Those Who Enquire About Health and Social Care Services Overview This standard identifies the requirements when you provide advice and information

More information

Report on Guidelines for Health economic analyses of medicinal products

Report on Guidelines for Health economic analyses of medicinal products Anita Alban Hans Keiding Jes Søgaard March 1998 Report on Guidelines for Health economic analyses of medicinal products In 1997, the Danish Ministry of Health set up a working group consisting of: Research

More information

The rules governing medicinal products in the European Union. Presentation and content of the dossier Edition

The rules governing medicinal products in the European Union. Presentation and content of the dossier Edition The rules governing medicinal products in the European Union Volume 2B Notice to Applicants Medicinal products for human use Presentation and content of the dossier 1998 Edition EUROPEAN COMMISSION Directorate

More information

Laws and regulations related to animal experiments in Japan

Laws and regulations related to animal experiments in Japan Education and Training for Animal Experiments Laws and regulations related to animal experiments in Japan Tatsuya Sakurai, D.V.M., Ph.D. Institutional Animal Care and Use Committee The Jikei University

More information

Joint safety evaluation of substances in printing inks by Germany (BfR) and Switzerland (FSVO)

Joint safety evaluation of substances in printing inks by Germany (BfR) and Switzerland (FSVO) Federal Department of Home Affairs FDHA Federal Food Safety and Veterinary Office FSVO Risk Assessment Division Joint safety evaluation of substances in printing inks by Germany (BfR) and Switzerland (FSVO)

More information

Memorandum to the Code of Conduct

Memorandum to the Code of Conduct Memorandum to the Code of Conduct Table of contents MEMORANDUM AND EXPLANATIONS Pertaining to article 1 3 Pertaining to article 2 3 Pertaining to article 3 3 Pertaining to article 4 4 Pertaining to article

More information

Guidelines. Approval of rolling stock

Guidelines. Approval of rolling stock BUNDESAMT FÜR VERKEHR OFFICE FÉDÉRAL DES TRANSPORTS UFFICIO FEDERALE DEI TRASPORTI FEDERAL OFFICE OF TRANSPORT Guidelines Articles 6a, 7 and 8 of the Ordinance on the Construction and Operation of Railways

More information

Provost and Vice-Chancellor for Academic Affairs

Provost and Vice-Chancellor for Academic Affairs 03.390 Institutional Animal Care and Use Committee Policy and Procedures Authority: Provost and Vice-Chancellor for Academic Affairs History: September 2, 2009 Source of Authority: Related Policies: Responsible

More information

WICHITA STATE UNIVERSITY INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC) ANIMAL PROTOCOL FORM

WICHITA STATE UNIVERSITY INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC) ANIMAL PROTOCOL FORM WICHITA STATE UNIVERSITY INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC) ANIMAL PROTOCOL FORM Date: Principal Investigator: Title of Project: Protocol #: Animal Species: Anticipated Start Date: Anticipated

More information

MANUAL: Administrative Policy & Procedure Manual POLICY:

MANUAL: Administrative Policy & Procedure Manual POLICY: SJMHS Locations: St. Joseph Mercy Ann Arbor, St. Joseph Mercy Chelsea, St. Joseph Mercy Livingston, St. Mary Mercy Livonia MANUAL: Administrative Policy & Procedure Manual POLICY: Expanded access is the

More information

Guide to DSI s. Telemetry Devices. Continuous, real-time In Vivo Physiologic Monitoring Solutions for Animal Models

Guide to DSI s. Telemetry Devices. Continuous, real-time In Vivo Physiologic Monitoring Solutions for Animal Models Guide to DSI s Telemetry Devices Continuous, real-time In Vivo Physiologic Monitoring Solutions for Animal Models Telemetry Devices from DSI able Telemetry DSI's PhysioTel implants are designed for acquiring

More information

EIGHT BASIC ELEMENTS OF INFORMED CONSENT

EIGHT BASIC ELEMENTS OF INFORMED CONSENT 1/6 This guidance addresses: o Eight Basic elements of informed consent o Additional elements of informed consent o Other information required by the IRB EIGHT BASIC ELEMENTS OF INFORMED CONSENT Required

More information

Ohio University Institutional Animal Care and Use Committee Policy Manual

Ohio University Institutional Animal Care and Use Committee Policy Manual Ohio University Institutional Animal Care and Use Committee Policy Manual I. Regulatory Ohio University maintains an institutional animal care and use program with U.S. Department of Agriculture (USDA)

More information

eacuc Protocol Guide (Click Bookmarks to navigate through this document after saving as an Adobe PDF file)

eacuc Protocol Guide (Click Bookmarks to navigate through this document after saving as an Adobe PDF file) I. Study Identification 1.0 Protocol Title: Must match the grant/project title exactly if this is a funded study. 2.0 PI: Automatically entered; only indicate a Co-Investigator if they are named on the

More information

University of California, Berkeley Animal Care and Use Program

University of California, Berkeley Animal Care and Use Program Version: 3 Effective Date: July 1, 2017 POLICY ON PROTOCOL REVIEW Supercedes Document Dated: February 8, 2017 I. Background The Public Health Service (PHS) Policy as well as the US Department of Agriculture

More information

Technical Guidance on Development of In Vitro Companion Diagnostics and Corresponding Therapeutic Products

Technical Guidance on Development of In Vitro Companion Diagnostics and Corresponding Therapeutic Products Administrative Notice December 26, 2013 To: Division of Pharmaceutical Affairs, Prefectural Health Department (Bureau) From: Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau Ministry

More information

Guidelines to the project licence application form

Guidelines to the project licence application form Guidelines to the project licence application form In these guidelines, the three documents that constitute the project licence application form will be discussed: Project licence application for animal

More information

Information on the focal point for the Convention. Information on the point of contact for the Convention

Information on the focal point for the Convention. Information on the point of contact for the Convention Questionnaire for the REPORT OF MONTENEGRO ON THE IMPLEMENTATION OF THE CONVENTION ON ENVIRONMENTAL IMPACT ASSESSMENT IN A TRANSBOUNDARY CONTEXT in the period 2006 2009 Information on the focal point for

More information

REFERENCE LIBRARY Document Cover Page

REFERENCE LIBRARY Document Cover Page REFERENCE LIBRARY Document Cover Page Guide to the Control System (Instruction Manual) Adopted by the fourth meeting of the Conference of the Parties, Kuching, Malaysia February 1998 This electronic document

More information

Working with Animals. Walter Jeske, PhD Professor, Thoracic & CV Surgery, Pathology, Physiology Vice-chair, IACUC 02/27/14

Working with Animals. Walter Jeske, PhD Professor, Thoracic & CV Surgery, Pathology, Physiology Vice-chair, IACUC 02/27/14 Working with Animals Walter Jeske, PhD Professor, Thoracic & CV Surgery, Pathology, Physiology Vice-chair, IACUC 02/27/14 Animal research is as carefully regulated as human research but for different

More information

FOR OFFICE USE ONLY. IACUC PROTOCOL NUMBER: IACUC Approval has been granted for the project described in this document

FOR OFFICE USE ONLY. IACUC PROTOCOL NUMBER: IACUC Approval has been granted for the project described in this document ADMINISTRATIVE COVER SHEET FOR AN APPLICATION TO USE LIVE VERTEBRATE ANIMALS IN FIELD RESEARCH Arkansas Tech University Institutional Animal Care and Use Committee (IACUC) FOR OFFICE USE ONLY IACUC PROTOCOL

More information

Guideline for the conduct of efficacy studies for nonsteroidal anti-inflammatory drugs

Guideline for the conduct of efficacy studies for nonsteroidal anti-inflammatory drugs 1 2 3 4 5 6 7 8 8 November 2012 EMA/CVMP/EWP/1061/2001-CONSULTATION Committee for Medicinal Products for Veterinary Use (CVMP) Guideline for the conduct of efficacy studies for nonsteroidal anti-inflammatory

More information

INSTITUTIONAL ANIMAL ETHICS COMMITTEE SUMMARY SHEET (TO BE FILLED BY INVESTIGATOR)

INSTITUTIONAL ANIMAL ETHICS COMMITTEE SUMMARY SHEET (TO BE FILLED BY INVESTIGATOR) INSTITUTIONAL ANIMAL ETHICS COMMITTEE SUMMARY SHEET (TO BE FILLED BY INVESTIGATOR) 1. Type of Animals used (Please Tick) Number of Animals requested a. Mice b. Rats c. Rabbits d. Hamster e. Primates f.

More information

Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL EUROPEAN COMMISSION Brussels, 13.12.2016 COM(2016) 788 final 2016/0393 (COD) Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulation (EC) No 1059/2003 as regards the

More information

Institutional Animal Ethics Committee Animal House, School of Biological Sciences, NISER, Bhubaneswar. Summary Sheet (To be filled by Investigator)

Institutional Animal Ethics Committee Animal House, School of Biological Sciences, NISER, Bhubaneswar. Summary Sheet (To be filled by Investigator) Institutional Animal Ethics Committee Animal House, School of Biological Sciences, NISER, Bhubaneswar Name of the Principal Investigator: Designation: Summary Sheet (To be filled by Investigator) Contact

More information

Animal Research: The Benefits Outweigh the Costs. Alexis Miller. Loras College

Animal Research: The Benefits Outweigh the Costs. Alexis Miller. Loras College Miller 1 Animal Research: The Benefits Outweigh the Costs Alexis Miller Loras College Miller 2 Animal research has become a controversial ethical topic in psychology today. There are many different opinions

More information

AEAI 38 EERAL ACCOUNTING OFFICE WASHINGTON DC HU04AN RESOUR--ETC Ff6 6/5 ALTERNATIVES TO USE OF ANIMALS IN RESEARCH. CU) MAR Ga 6 1 AHART

AEAI 38 EERAL ACCOUNTING OFFICE WASHINGTON DC HU04AN RESOUR--ETC Ff6 6/5 ALTERNATIVES TO USE OF ANIMALS IN RESEARCH. CU) MAR Ga 6 1 AHART AEAI 38 EERAL ACCOUNTING OFFICE WASHINGTON DC HU04AN RESOUR--ETC Ff6 6/5 ALTERNATIVES TO USE OF ANIMALS IN RESEARCH. CU) MAR Ga 6 1 AHART UNCLASSIFIED GAO/H 0D-80-70 GAO United States General Accounting

More information

COMMON MARKET OF MEDICINES OF THE EURASIAN ECONOMIC UNION: RULES OF GOOD CLINICAL PRACTICE AND GOOD LABORATORY PRACTICE

COMMON MARKET OF MEDICINES OF THE EURASIAN ECONOMIC UNION: RULES OF GOOD CLINICAL PRACTICE AND GOOD LABORATORY PRACTICE COMMON MARKET OF MEDICINES OF THE EURASIAN ECONOMIC UNION: RULES OF GOOD CLINICAL PRACTICE AND GOOD LABORATORY PRACTICE www.gratanet.com Among other regulations aimed at the implementation of the Agreement

More information

GUIDELINES ON MEDICAL DEVICES

GUIDELINES ON MEDICAL DEVICES EUROPEAN COMMISSION DG Internal Market, Industry, Entrepreneurship and SMEs Consumer, Environmental and Health Technologies Health technology and Cosmetics MEDDEV 2.7/3 revision 3 May 2015 GUIDELINES ON

More information

COMMENTS FROM EUROPABIO GENERAL COMMENTS

COMMENTS FROM EUROPABIO GENERAL COMMENTS SUBMISSION OF COMMENTS ON DETAILED GUIDANCE FOR THE REQUEST FOR AUTHORISATION OF A CLINICAL TRIAL ON A MEDICINAL PRODUCT FOR HUMAN USE TO THE COMPETENT AUTHORITIES, NOTIFICATION OF SUBSTANTIAL AMENDMENTS

More information

Comments and suggestions from reviewer

Comments and suggestions from reviewer Comments and suggestions from reviewer Page 1 of 13 Title: WHO Guidelines on the Quality, Safety, and Efficacy of Biological Medicinal Products Prepared by Recombinant DNA Technology: WHO/rDNA_DRAFT/12

More information

Ordinance on the Fees charged by the Swiss Agency for Therapeutic Products (Therapeutic Products Fees Ordinance)

Ordinance on the Fees charged by the Swiss Agency for Therapeutic Products (Therapeutic Products Fees Ordinance) Ordinance on the Fees charged by the Swiss Agency for Therapeutic Products (Therapeutic Products Fees Ordinance) of 2 December 2011 (Stand am 1. Januar 2015) The Agency Council of the Swiss Agency for

More information

Assessment plan for Animal Technologist Apprenticeship (Level 3)

Assessment plan for Animal Technologist Apprenticeship (Level 3) Assessment plan for Animal Technologist Apprenticeship (Level 3) Summary of Assessment The formal end-point assessment will consist of: A synoptic interview (informed by a portfolio of evidence developed

More information

1 R21 AI A1 2 VMD HALFORD, W

1 R21 AI A1 2 VMD HALFORD, W 1 R21 AI081072-01A1 2 VMD 1R21AI081072-01A1 ILLIAM RESUME AND SUMMARY OF DISCUSSION: The proposed study is to develop safe and effective live attenuated vaccines against herpes simplex virus 2 by using

More information

Safety Standards. of the Nuclear Safety Standards Commission (KTA) Requirements for the Testing Manual

Safety Standards. of the Nuclear Safety Standards Commission (KTA) Requirements for the Testing Manual Safety Standards of the Nuclear Safety Standards Commission (KTA) KTA 1202 (2017-11) Requirements for the Testing Manual (Anforderungen an das Prüfhandbuch) The previous versions of this safety standard

More information

GUIDELINES ON MEDICAL DEVICES

GUIDELINES ON MEDICAL DEVICES Ref. Ares(2016)1982736-26/04/2016 EUROPEAN COMMISSION DG Internal Market, Industry, Entrepreneurship and SMEs Consumer, Environmental and Health Technologies Health technology and Cosmetics MEDDEV 2.7/3

More information

Clinical studies. BARBORA VLKOVÁ INSTITUTE OF MOLECULAR BIOMEDICINE

Clinical studies. BARBORA VLKOVÁ INSTITUTE OF MOLECULAR BIOMEDICINE Clinical studies BARBORA VLKOVÁ INSTITUTE OF MOLECULAR BIOMEDICINE www.imbm.sk barboravlk@gmail.com Biomedical research 1. Basic research a. In vitro = cell cultures b. In vivo = experimental animals c.

More information

The ethics of research involving animals

The ethics of research involving animals The ethics of research involving animals a guide to the Report Introduction Research involving animals has been the subject of intense debate in the UK and elsewhere. Too often this debate is presented

More information

NEW MEXICO HIGHLANDS UNIVERSITY ANIMAL STUDY PROPOSAL

NEW MEXICO HIGHLANDS UNIVERSITY ANIMAL STUDY PROPOSAL NEW MEXICO HIGHLANDS UNIVERSITY ANIMAL STUDY PROPOSAL Proposal #: Leave Blank PLEASE TYPE A. ADMINISTRATIVE DATA Approval Date: Expiration Date: Department: Principal Investigator: Mailing Address: Telephone:

More information

PACUC Newsletter. PACUC Personnel Changes. Vol. 18, No. 1, March ~ ~ ~ ~ Brown Bag Seminars for Animal Users

PACUC Newsletter. PACUC Personnel Changes. Vol. 18, No. 1, March ~ ~ ~ ~ Brown Bag Seminars for Animal Users PACUC Newsletter Purdue Animal Care and Use Committee http://www.purdue.edu/research/ora/animals/animals-main.shtml Purdue University Vol. 18, No. 1, March 2003 E PACUC Personnel Changes ffective January

More information

Higher National Unit Specification. General information for centres. Unit code: F3TX 34

Higher National Unit Specification. General information for centres. Unit code: F3TX 34 Higher National Unit Specification General information for centres Unit title: Animal Welfare Unit code: F3TX 34 Unit purpose: This Unit provides knowledge and understanding necessary for working within

More information

Human Tissue Act 2004: The age of consent arrives in the UK Gillian Johnson and Alex Wilson Date received (in revised form): 30th June, 2005

Human Tissue Act 2004: The age of consent arrives in the UK Gillian Johnson and Alex Wilson Date received (in revised form): 30th June, 2005 Gillian Johnson is an associate in the Bio/Pharma Group of the London specialist intellectual property firm Bristows. Alex Wilson is a partner in the Bio/Pharma Group of the London specialist intellectual

More information

Regulation No. 281 of the Government of the Republic of Estonia of 28. September Procedure for Import, Export and Transit of Strategic Goods

Regulation No. 281 of the Government of the Republic of Estonia of 28. September Procedure for Import, Export and Transit of Strategic Goods Regulation No. 281 of the Government of the Republic of Estonia of 28. September 1999 Procedure for Import, Export and Transit of Strategic Goods I. General Provisions Para. 1. This Procedure regulates

More information

2. Starting Date: Completion Date: 3. Principal Investigator: Name: Mailing Address: Position: Department/Organization: Region/Institution:

2. Starting Date: Completion Date: 3. Principal Investigator: Name: Mailing Address: Position: Department/Organization: Region/Institution: FISH, WILDLIFE AND HABITAT MANAGEMENT BRANCH ANIMAL CARE APPLICATION FORM PLEASE TYPE For office use: Date Received: Project Number: 1. Project Title: 2. Starting Date: Completion Date: _ 3. Principal

More information

Writing an IACUC Protocol

Writing an IACUC Protocol Writing an IACUC Protocol 2014 Getting Started Download forms from IACUC website: http://www.umc.edu/research/iacuc/forms.aspx Check date on footer Current forms are dated 2014 Consultation with the LAF

More information

Gary L. Moulder, MS. Director, CVRI Zebrafish Shared Facility at UCSF

Gary L. Moulder, MS. Director, CVRI Zebrafish Shared Facility at UCSF Hatching Fish When should animal tracking begin? Gary L. Moulder, MS. Director, CVRI Zebrafish Shared Facility at UCSF Abstract The National Institutes of Health: Final Report to Office of Laboratory Animal

More information

Exploring the Scientific and Laboratory Animals Industry

Exploring the Scientific and Laboratory Animals Industry Lesson B2 11 Exploring the Scientific and Laboratory Animals Industry Unit B. Animal Science and the Industry Problem Area 2. Identifying and Understanding the Segments of the Animal Science Industry Lesson

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL GUIDELINE FOR A LICENCE TO MANUFACTURE, IMPORT, EXPORT OR DISTRIBUTE MEDICAL DEVICES & IVDs This guideline is intended to provide recommendations to applicants wishing to submit

More information

Registration Application form for Vaccines (To be submitted in duplicate electronic copies)

Registration Application form for Vaccines (To be submitted in duplicate electronic copies) Cover letter addressed to: Registration Application form for Vaccines (To be submitted in duplicate electronic copies) THE CHIEF EXECUTIVE FOOD AND DRUGS AUTHORITY P. O. BOX CT 2783 CANTONMENTS-ACCRA GHANA.

More information